v3.26.1
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Securities available for sale, amortized cost $ 2,857,903 [1] $ 2,646,414 [2]
Securities held to maturity, fair value $ 2,227,000 [3] $ 2,246,526 [4]
Common stock, par value (usd per share) $ 0.01 $ 0.01
Common stock, outstanding (in shares) 153,722,123 149,963,520
Common stock, issued (in shares) 153,784,724 150,039,018
Allowance for Credit Loss $ (775) $ (775)
Class B Nonvoting    
Common stock, par value (usd per share) $ 0.01 $ 0.01
Common stock, outstanding (in shares) 477,321  
Common stock, issued (in shares) 477,321 477,321
Nonvoting Common Stock    
Common stock, par value (usd per share) $ 0.01 $ 0.01
Common stock, issued (in shares) 0 5,017,064
Credit-linked notes    
Credit-linked Notes $ 111,250 $ 113,634
[1] Excludes accrued interest receivable of $12.3 million at March 31, 2026 which is recorded in "Other assets" on the consolidated balance sheets.
[2] Excludes accrued interest receivable of $11.4 million at December 31, 2025 which is recorded in "Other assets" on the consolidated balance sheets.
[3] Excludes accrued interest receivable of $11.2 million at March 31, 2026 which is recorded in "Other assets" on the consolidated balance sheet
[4] Excludes accrued interest receivable of $13.4 million at December 31, 2025 which is recorded in "Other assets" on the consolidated balance sheets